share_log

ADRs End Lower; Onion Global, Wolters Kluwer Among Companies Actively Trading

ADRs End Lower; Onion Global, Wolters Kluwer Among Companies Actively Trading

美國存託憑證收盤走低;洋葱環球、沃爾特斯·克魯沃等公司交易活躍
Dow Jones Newswires ·  2021/10/29 19:02
   By Kimberly Chin 
作者:金伯利·陳(Kimberly Chin)

International stocks trading in New York finished lower on Friday. The S&P/BNY Mellon index of American depositary receipts fell 1.3% to 164.33. The European index slipped 0.7% to 147.31. The Asian index declined 2% to 219.67. The Latin American index decreased 2.6% to 175.34. And the emerging-markets index tumbled 2.4% to 360.25.

週五,紐約國際股市收盤走低。S&P/紐約梅隆美國存託憑證指數跌1.3%,報164.33點。歐洲指數下滑0.7%,至147.31點。亞洲指數下跌2%,至219.67點。拉丁美洲指數下跌2.6%,至175.34。新興市場指數暴跌2.4%,至360.25點。

Onion Global Ltd.'s ADRs declined 38% after the company said it agreed with certain institutional and accredited investors to raise $25 million in a private placement.

洋葱環球有限公司(Onion Global Ltd.)的美國存託憑證(ADR)下跌38%,此前該公司表示,已與某些機構和認可投資者達成一致,將通過私募募集2,500萬美元。

ADRs of Wolters Kluwer NV, which trade over the counter, tumbled 1.7% after the company said Friday that it has acquired LicenseLogix LLC, a provider of U.S. business licensing services. The Netherlands-based information, software and services company said the deal is expected to have an immaterial impact on its adjusted earnings for the first full year.

在場外交易的Wolters Kluwer NV的ADR暴跌1.7%,此前該公司週五表示,已收購美國商業許可服務提供商LicenseLogix LLC。這家總部位於荷蘭的信息、軟件和服務公司表示,預計這筆交易將對其第一個全年的調整後收益產生無形的影響。

Banco Bilbao Vizcaya Argentaria SA's ADRs rose 5.8% after the Spanish bank reported a rise in third-quarter profit and said it received the go-ahead to launch a buyback program.

西班牙畢爾巴鄂比茲卡亞銀行(Banco Bilbao Vizcaya)的美國存託憑證(ADR)上漲5.8%,此前這家西班牙銀行公佈第三季度利潤上升,並表示已獲得啟動回購計劃的許可。

Novo Nordisk AS's ADRs rose 2.3% Friday after the Danish pharmaceutical company raised its full-year sales and operating profit guidance to reflect higher-than-expected market share gains in its Ozempic glucagon-like peptide-1 drug (GLP-1) for treating type 2 diabetes, GLP-1 market growth and obesity-care sales, mainly in the U.S.

諾和諾德(Novo Nordisk)股價上週五上漲2.3%,此前這家丹麥製藥公司上調了全年銷售和營業利潤指引,以反映其治療2型糖尿病的Ozempic胰高血糖素樣肽-1(GLP-1)的市場份額增長高於預期,GLP-1的市場增長以及主要在美國的肥胖護理銷售。

Write to Kimberly Chin at kimberly.chin@wsj.com

寫信給Kimberly Chin,電子郵件:kimberly.chin@wsj.com

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論